Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Trubion Pharmaceuticals, Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Trubion Pharmaceuticals, Inc since year 2005.
Table 2 shows the detailed insider transactions of Trubion Pharmaceuticals, Inc since 2005.
The reporting company's ticker symbol is TRBN. The reporting company's CIK number is 1298521.
The total value of stock buying since 2005 is $7,131,104.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $39,685.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2010-10-28||Nelsen Robert (10% Owner)||Sale||2,357,046||.00||0|
|2009-05-22||Thompson Peter A (President and CEO)||Option Ex||126,387||.31||39,685|
|2008-09-05||Mann David A (Director)||Buy||1,600||4.27||6,831|
|2008-09-04||Mann David A (Director)||Buy||1,400||4.20||5,880|
|2008-09-03||Mann David A (Director)||Buy||1,000||4.15||4,150|
|2007-11-20||Mann David A (Director)||Buy||4,000||10.00||40,000|
|2007-11-19||Thompson Peter A (President and CEO)||Buy||5,000||9.99||49,935|
|2006-12-01||Mann David A (Director)||Buy||1,935||18.62||36,025|
|2006-11-29||Mann David A (Director)||Buy||3,000||18.50||55,500|
|2006-10-23||Hove Anders D (Director)||Buy||35,181||13.00||457,353|
|2006-10-23||Venrock Entrepreneurs Fund Iv, L.p. (10% Owner)||Buy||704||13.00||9,152|
|2006-10-23||Venrock Associates Iv, L.p. (10% Owner)||Buy||28,637||13.00||372,281|
|2006-10-23||Vef Management Iv, Llc (10% Owner)||Buy||704||13.00||9,152|
|2006-10-23||Venrock Partners Management, Llc (10% Owner)||Buy||5,840||13.00||75,920|
|2006-10-23||Venrock Partners, L.p. (10% Owner)||Buy||5,840||13.00||75,920|
|2006-10-23||Venrock Management Iv, Llc (10% Owner)||Buy||28,637||13.00||372,281|
|2006-10-18||Thompson Peter A (President and CEO)||Buy||1,000||13.00||13,000|
|2006-10-18||Heron Patrick (Director)||Buy||42,384||13.00||550,992|
|2006-10-18||Gillis Steven (Director)||Buy||44,640||13.00||580,320|
|2006-10-18||Frazier Affiliates Iv Lp (10% Owner)||Buy||42,384||13.00||550,992|
|2006-10-17||Obp Management Iv Lp (10% Owner)||Buy||41,614||13.00||540,982|
|2006-10-17||Schnell David (Director)||Buy||70,362||13.00||914,706|
|2006-10-17||Barkas Alexander E (10% Owner)||Buy||70,362||13.00||914,706|
|2006-10-17||Lazarus Steven (10% Owner)||Buy||44,640||13.00||580,320|
Insider trading activities including stock purchases, stock sales, and option exercises of TRBN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Trubion Pharmaceuticals, Inc (symbol TRBN, CIK number 1298521) see the Securities and Exchange Commission (SEC) website.